Mercer Global Advisors’s Virtus Biotech ETF BBP Stock Holding History

Mercer Global Advisors’s Portfolio BBP Stock Details BBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.56K	Buy	+37	New	+$3.22K	﹤0.01%	5451

Other funds holding BBP

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

WBI Investments Red Bank, New Jersey $403M AUM 42.23% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $10.3B AUM 25.54% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ARC

Advisor Resource Council Dallas, Texas $355M AUM 30.05% 1-Year Est. Return

IFG

Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return

Mercer Global Advisors's BBP Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Virtus Biotech ETF (BBP) in Q2 2026: 37 shares worth $3.56K. The stake represents ﹤0.01% of the portfolio and ranks #5451 among its holdings.

19 funds tracked by Wall St. Rank hold BBP as of Q2 2026.

Mercer Global Advisors held 37 shares of Virtus Biotech ETF worth $3.56K as of Q2 2026.
Virtus Biotech ETF was a new Mercer Global Advisors position in Q2 2026.
Virtus Biotech ETF made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5451 holding.
19 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.